alexa Long-term treatment of depression with isocarboxazide.
Healthcare

Healthcare

Health Care : Current Reviews

Author(s): Larsen JK, Rafaelsen OJ

Abstract Share this page

Abstract Isocarboxazide has been used as long-term treatment for a selected group of 20 depressive patients, of whom some 90\% (17/19) were non-responders to treatment with tricyclic antidepressants. At the follow-up the median duration of illness was 162 months, and the median duration of treatment was 42 months. Side-effects and interactions were moderate thus legitimating a treatment procedure on which all the patients of the material responded better than on any other antidepressive treatment. Treatment with monoamine-oxidase-inhibitors, like isocarboxazide, should not be left untried in the case of therapy-resistant depression.
This article was published in Acta Psychiatr Scand and referenced in Health Care : Current Reviews

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords